| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Division of Gastroenterology, Washington University, Saint Louis, Missouri; and 2 Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, Virginia
Prostaglandins may play an important role in
regulating normal renewal of gastrointestinal epithelium, epithelial
injury repair, and initiation or progression of intestinal neoplasia. Synthesis of prostaglandins is catalyzed by either of two
cyclooxygenase isoforms, Cox-1 and Cox-2. Cox-1 is the predominant
cyclooxygenase isoform found in the normal intestine. In contrast,
Cox-2 is present at low levels in normal intestine but is elevated at
sites of inflammation and in adenomas and carcinomas. To determine
directly whether prostaglandins synthesized by Cox-1 or Cox-2 regulate crypt epithelial cell fate after genotoxic or cytotoxic injury, we
examined apoptosis, prostaglandin synthesis, and crypt stem cell
survival after 
-irradiation in Cox-1
/ and
Cox-2/ mice. Cox-1/ mice had increased
crypt epithelial cell apoptosis and decreased clonogenic stem cell
survival compared with wild-type littermates. PGE2
synthesis was also diminished in Cox-1/ mice compared
with wild-type controls in unstressed intestine and after radiation
injury. In contrast, apoptosis, stem cell survival, and intestinal
PGE2 synthesis in Cox-2/ mice after
irradiation were the same as in wild-type littermates. Crypt stem cell
survival after irradiation was inhibited by a highly specific
neutralizing antibody to PGE2, suggesting that this
prostaglandin mediates stem cell fate in vivo. These data suggest that
prostaglandins synthesized by Cox-1 regulate multiple steps that
determine the fate of crypt epithelial cell after genotoxic or
cytotoxic injury.
cyclooxygenase; ionizing radiation; prostaglandin E2; intestinal epithelium; gastrointestinal malignancy
This article has been cited by other articles:
|
|
 |
|
  R. J. George, M. A. Sturmoski, R. May, S. M. Sureban, B. K. Dieckgraefe, S. Anant, and C. W. Houchen Loss of p21Waf1/Cip1/Sdi1 enhances intestinal stem cell survival following radiation injury Am J Physiol Gastrointest Liver Physiol, February 1, 2009; 296(2): G245 - G254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Skill, N. G. Theodorakis, Y. N. Wang, J. M. Wu, E. M. Redmond, and J. V. Sitzmann Role of cyclooxygenase isoforms in prostacyclin biosynthesis and murine prehepatic portal hypertension Am J Physiol Gastrointest Liver Physiol, November 1, 2008; 295(5): G953 - G964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Scarpignato NSAID-induced intestinal damage: are luminal bacteria the therapeutic target? Gut, February 1, 2008; 57(2): 145 - 148. [Full Text] [PDF]
|
|
|
|
|
|
T. E. Riehl, R. J. George, M. A. Sturmoski, R. May, B. Dieckgraefe, S. Anant, and C. W. Houchen Azoxymethane protects intestinal stem cells and reduces crypt epithelial mitosis through a COX-1-dependent mechanism Am J Physiol Gastrointest Liver Physiol, December 1, 2006; 291(6): G1062 - G1070. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chandrasekharan, N. A. Foley, L. Jania, P. Clark, L. P. Audoly, and B. H. Koller Coupling of COX-1 to mPGES1 for prostaglandin E2 biosynthesis in the murine mammary gland J. Lipid Res., December 1, 2005; 46(12): 2636 - 2648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Murmu, J. Jung, D. Mukhopadhyay, C. W. Houchen, T. E. Riehl, W. F. Stenson, A. R. Morrison, T. Arumugam, B. K. Dieckgraefe, and S. Anant Dynamic antagonism between RNA-binding protein CUGBP2 and cyclooxygenase-2-mediated prostaglandin E2 in radiation damage PNAS, September 21, 2004; 101(38): 13873 - 13878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, A. Meng, H. Lang, S. A. Brown, J. L. Konopa, M. S. Kindy, R. A. Schmiedt, J. S. Thompson, and D. Zhou Activation of Nuclear Factor {kappa}B In vivo Selectively Protects the Murine Small Intestine against Ionizing Radiation-Induced Damage Cancer Res., September 1, 2004; 64(17): 6240 - 6246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Davis, J. M. O'Neal, M. D. Pagel, B. S. Zweifel, P. P. Mehta, D. M. Heuvelman, and J. L. Masferrer Synergy between Celecoxib and Radiotherapy Results from Inhibition of Cyclooxygenase-2-Derived Prostaglandin E2, a Survival Factor for Tumor and Associated Vasculature Cancer Res., January 1, 2004; 64(1): 279 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. Tessner, F. Muhale, S. Schloemann, S. M. Cohn, A. R. Morrison, and W. F. Stenson Ionizing radiation up-regulates cyclooxygenase-2 in I407 cells through p38 mitogen-activated protein kinase Carcinogenesis, January 1, 2004; 25(1): 37 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Riehl, R. D. Newberry, R. G. Lorenz, and W. F. Stenson TNFR1 mediates the radioprotective effects of lipopolysaccharide in the mouse intestine Am J Physiol Gastrointest Liver Physiol, January 1, 2004; 286(1): G166 - G173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Choy and L. Milas Enhancing Radiotherapy With Cyclooxygenase-2 Enzyme Inhibitors: A Rational Advance? J Natl Cancer Inst, October 1, 2003; 95(19): 1440 - 1452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Houchen, M. A. Sturmoski, S. Anant, R. M. Breyer, and W. F. Stenson Prosurvival and antiapoptotic effects of PGE2 in radiation injury are mediated by EP2 receptor in intestine Am J Physiol Gastrointest Liver Physiol, March 1, 2003; 284(3): G490 - G498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. G. Tessner, F. Muhale, S. Schloemann, S. M. Cohn, A. Morrison, and W. F. Stenson Basic fibroblast growth factor upregulates cyclooxygenase-2 in I407 cells through p38 MAP kinase Am J Physiol Gastrointest Liver Physiol, February 1, 2003; 284(2): G269 - G279. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
